Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
The case for shorter antibiotic courses keeps getting stronger. Evidence shows that briefer treatments are often just as effective as longer ones for common infections, while reducing side effects and the risk of antibiotic resistance. Primary care clinicians — who account for ~80% of antibiotic prescribing — are increasingly being urged to embrace the "less is more" approach.
The medical community is increasingly rallying around a counterintuitive idea: when it comes to antibiotics, shorter is often better. A growing body of evidence — backed by updated guidelines from the American College of Physicians (ACP), the Infectious Diseases Society of America (IDSA), and others — shows that shorter antibiotic courses are noninferior in effectiveness for many common infections, while carrying fewer side effects and a lower risk of fueling antibiotic resistance.
Clinicians emphasize that this shift is about smarter prescribing, not withholding care. Longer courses don't prevent resistance — they actually worsen it by sustaining selection pressure on bacteria. They also disrupt the gut microbiome, sometimes causing serious secondary infections like C. difficile. The key is pairing shorter durations with careful assessment of clinical stability, not letting patients stop early on their own.
Key Takeaways:
Why it matters: With primary care clinicians driving ~80% of antibiotic prescribing, adopting shorter, evidence-based courses could meaningfully curb antibiotic resistance — one of the most pressing global health threats — while improving patient outcomes and preserving gut health.
